IP Library › Patent Application 13614715
Patent Application
App. No. 13/614,715

Methods of Treating Autism

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/614,715
Abstract

Subjects having autism are treated with a composition that includes gamma-aminobutyric acid agonists. The gamma-aminobutyric acid agonist (GABA) can be a GABA(B) agonist, such as baclofen.

Claims (2)

1 . A method of improving at least one of motivation, calmness, class participation, ability to tolerate stress and sleep patterns in a human having autism spectrum disorder, comprising the step of orally administering to the human a composition that includes a therapeutically effective amount of at least one GABA(B) agonist.

2 . The method of claim 1 , wherein the GABA(B) agonist is administered to the human in a dose of about 0.001 mg/kg/day to about 5 mg/kg/day.

Assignments (2)
CHANGE OF NAME Recorded Feb 27, 2013
From: SEASIDE THERAPEUTICS, LLC
To: SEASIDE THERAPEUTICS, INC.
Reel/Frame 029891/0351 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2013
From: BEAR, MARK F.; ROBERTS, KATHRYN; CARPENTER, RANDALL L.
To: SEASIDE THERAPEUTICS, LLC
Reel/Frame 029813/0733 →